Arcutis Biotherapeutics, Inc. (ARQT) ownership: Top institutional holder: SUVRETTA CAPITAL MANAGEMENT, LLC ($290.42M). Insider activity: Net Seller (0 buys, 20 sells). 6 recent congressional STOCK Act disclosures. SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 12327000.00 | $290.42M | 2026-03-31 |
| Frazier Life Sciences Management, L.P. | 9874511.00 | $232.64M | 2026-03-31 |
| BlackRock, Inc. | 9200411.00 | $216.76M | 2026-03-31 |
| VANGUARD GROUP INC | 7253936.00 | $210.65M | 2025-12-31 |
| Rubric Capital Management LP | 8271577.00 | $194.88M | 2026-03-31 |
| STATE STREET CORP | 6296197.00 | $148.34M | 2026-03-31 |
| Polar Capital Holdings Plc | 5666940.00 | $133.51M | 2026-03-31 |
| JENNISON ASSOCIATES LLC | 4980770.00 | $117.35M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-05 | |
| Sell | null | 2026-06-05 | |
| Sell | null | 2026-06-05 | |
| Sell | null | 2026-06-05 | |
| Sell | null | 2026-06-05 | |
| Sell | null | 2026-06-05 | |
| Sell | null | 2026-06-05 | |
| Sell | null | 2026-06-05 |
Back to ARQT overview · ARQT earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.